dsm-firmenich secures 3-FL HMO market access in Europe

dsm-firmenich has secured European market access for its 3-fucosyllactose (3-FL) ingredient, one of the most abundant human milk oligosaccharides (HMO) in human milk.

Related Keywords

Marta Miks ,Panel On Nutrition ,Senior Regulatory Scientific Affairs ,European Commission ,Regulatory Affairs ,European Food Safety Authority ,Novel Food ,Scientific Opinion ,Novel Foods ,Food Allergens ,Senior Regulatory ,Scientific Affairs Manager ,Business ,Dairy ,Iet And Health ,Imo ,Regulation ,